Injection site reactions, including erythema, pruritus, and nodule formation (particularly with extended-release formulations), occur in approximately 10-20% of patients
In summary, GLP-1 RAs, through weight loss and the reduction of pro-inflammatory cytokines [31, 33], could provide a complementary approach to standard therapies for HS, especially in patients with obesity [36]
Red Understanding the Compounding Process Compounding is a long-standing practice in pharmacy that allows for medications to be tailored to the individual
So, it's clear that we should take the weight-loss benefit claims of these supplements with a pinch of salt, but is there a place for them in the treatment of insulin-sensitive conditions such as PCOS and pre-diabetes